Verona Pharma to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update
LONDON and RALEIGH, N.C., Feb. 18, 2021 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA)…
Month: February 2021
Change of EU home Member State
THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION Acacia Pharma Group plc Change of EU home Member State…
PCI Biotech: Invitation to fourth quarter 2020 results presentation
Oslo, Norway, 18 February 2021 – PCI Biotech’s (OSE: PCIB) fourth quarter and preliminary full…
Y-mAbs Announces Pricing of Public Offering of Common Stock
NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)…
Immunicum AB (publ) Announces Year-End Results 2020
Press Release 18 February 2021 Immunicum AB (publ) Announces Year-End Results 2020 OCTOBER-DECEMBER IN SUMMARY…
In Vitro Study Published in The New England Journal of Medicine Demonstrates Sera from Individuals Immunized with the Pfizer-BioNTech COVID-19 Vaccine Neutralize SARS-CoV-2 with South African Variant Spike Mutations
New York, NY and Mainz, Germany, February 17, 2021 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE:…
Optinose Announces Reporting Date for Fourth Quarter 2020 Financial Results
Conference Call and Webcast to be held March 3, 2021 at 8:00 a.m. Eastern Time…
NexImmune Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
GAITHERSBURG, Md., Feb. 17, 2021 (GLOBE NEWSWIRE) — NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology…
Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, Feb. 17, 2021 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare…
Better Choice Company Retains Emerging Markets Consulting, LLC (EMC) and Winning Media to Provide Investor/Public Relations Services
NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) — Better Choice Company (OTCQB: BTTR) (“Better Choice”),…
Myovant Sciences and Pfizer Announce Publication in the New England Journal of Medicine of Phase 3 LIBERTY Studies of Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids
LIBERTY 1 and LIBERTY 2 achieved 73.4% and 71.2% response rates in menstrual blood loss,…
Golden Leaf Announces Non-Brokered Private Placement of up to C$11,000,000
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY OR…
Diffusion Pharmaceuticals Announces Closing of $30 Million Bought Deal Offering of Common Stock
CHARLOTTESVILLE, Va., Feb. 17, 2021 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the…
Chinook Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
VANCOUVER, British Columbia and SEATTLE, Feb. 17, 2021 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (NASDAQ:…
Codiak Announces Closing of $66.4 Million Public Offering, Including Full Exercise of Underwriters’ Option
CAMBRIDGE, Mass., Feb. 17, 2021 (GLOBE NEWSWIRE) — Codiak BioSciences, Inc. (Nasdaq: CDAK) (“Codiak”), a…
Corvus Pharmaceuticals Announces Closing of Public Offering of Common Stock
BURLINGAME, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical…
Talis Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
MENLO PARK, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) — Talis Biomedical Corporation (Nasdaq: TLIS), a…
Shockwave Medical Reports Fourth Quarter and Full Year 2020 Financial Results
SANTA CLARA, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a…
Nkarta Announces February and March 2021 Investor Conference Schedule
SOUTH SAN FRANCISCO, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) — Nkarta, Inc. (Nasdaq: NKTX), a…
vTv Therapeutics Announces Initiation of Multiple Ascending Dose Study of HPP737, an Oral PDE4 Inhibitor for the Treatment of Psoriasis
Phase 1 multiple ascending dose study to evaluate safety of HPP737 in healthy volunteers and…